The Pasadena-based manufacturer is leveraging accredited third-party laboratories to screen products labeled as Ubiquinol, aiming to ensure they meet the quality standards of Kaneka’s proprietary yeast fermentation process. This initiative addresses concerns regarding synthetic alternatives, specifically the presence of cis-isomers often found in lower-quality CoQ10 products. By verifying that supplements are bioidentical to the body’s natural levels, the company intends to provide consumers with clearer, evidence-based purchasing data.

Kaneka Corporation has signaled that it will pursue legal and regulatory remedies should testing reveal significant discrepancies in product composition. The company continues to encourage both retailers and consumers to prioritize the Kaneka Quality Seal as a primary indicator of authenticity. These surveillance efforts follow a period of recognition for the brand, which secured multiple international awards in 2024 and 2025, including honors from the Functional Foods for Wellness Summit and NutraIngredients-Asia.